Skip to main content
×
Home
    • Aa
    • Aa

ASPIRIN ADMINISTRATION FOR PREVENTION OF ADVERSE PREGNANCY OUTCOMES

  • EMMANUEL BUJOLD (a1), STÉPHANIE ROBERGE (a1), SUZANNE DEMERS (a1) and KYPROS H NICOLAIDES (a2)
Abstract

The prophylactic use of low-dose aspirin for prevention of preeclampsia has been an important research question in obstetrics for the last three decades. In 1979, Crandon and Isherwood observed that nulliparous women who had taken aspirin regularly during pregnancy were less likely to have preeclampsia than women who did not. In 1985, Beaufils et al published the first randomized trial suggesting that 150 mg aspirin and 300 mg dipyridamole daily from 3 months’ gestation onwards decreased the risk of preeclampsia, fetal growth restriction and stillbirth in high-risk women. Subsequently, more than 50 trials have been carried out throughout the world and a meta-analysis of these studies reported that the administration of low-dose aspirin in high-risk pregnancies is associated with a decrease in the rate of preeclampsia by approximately 10%. Consequently, several national professional bodies recommend that high-risk pregnancies should be treated with aspirin (50–150 mg daily).

Copyright
Corresponding author
Emmanuel Bujold, MD, MSc, FRCSC, Associate Professor, Department of Obstetrics and Gynecology and Social and Preventive Medicine, Faculty of Medicine, Université Laval, 2705 boulevard Laurier, Québec City, QC, Canada, G1V 4G2. email: emmanuel.bujold@crchul.ulaval.ca
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

3 LM Askie , L Duley , DJ Henderson-Smart , LA Stewart . Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. Lancet 2007; 369: 1791–798.

6 SA Lowe , MA Brown , GA Dekker , S Gatt , CK McLintock , LP McMahon et al.Guidelines for the management of hypertensive disorders of pregnancy 2008. Aust N Z J Obstet Gynaecol 2009; 49: 242–46.

8 KH Nicolaides . Turning the pyramid of prenatal care. Fetal Diagn Ther 2011; 29: 183–96.

9 E Bujold , S Roberge , Y Lacasse , M Bureau , F Audibert , S Marcoux et al.Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 2010; 116: 402–14.

10 E Bujold , S Roberge , S Tapp , Y Giguere . Opinion & hypothesis could early aspirin prophylaxis prevent against preterm birth? J Matern Fetal Neonatal Med 2011; 24: 966–67.

14 A Bakhti , D Vaiman . Prevention of gravidic endothelial hypertension by aspirin treatment administered from the 8th week of gestation. Hypertension Research 2011; 34: 1116–120.

17 A Benigni , G Gregorini , T Frusca , C Chiabrando , S Ballerini , A Valcamonico et al.Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989; 321: 357–62.

19 RC Hermida , DE Ayala , M Iglesias , A Mojon , I Silva , R Ucieda et al.Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension 1997; 30: 589–95.

21 M Tulppala , M Marttunen , V Soderstrom-Anttila , T Foudila , K Ailus , T Palosuo et al.Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: Effect on prostacyclin and thromboxane a2 production. Hum Reprod 1997; 12: 1567–572.

22 M Vainio , E Kujansuu , M Iso-Mustajarvi , J Maenpaa . Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG 2002; 109: 161–67.

23 S Roberge , P Villa , K Nicolaides , Y Giguere , M Vainio , A Bakthi et al.Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: A systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141–46.

25Clasp: A randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Clasp (collaborative low-dose aspirin study in pregnancy) collaborative group. Lancet 1994; 343: 619–29.

26 JS Moldenhauer , J Stanek , C Warshak , J Khoury , B Sibai . The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003; 189: 1173–177.

27 NJ Sebire , RD Goldin , L Regan . Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity. J Obstet Gynaecol. 2005; 25: 117–18.

28 LJ Vatten , R Skjaerven . Is pre-eclampsia more than one disease? BJOG 2004; 111: 298302.

29 X Xiong , NN Demianczuk , LD Saunders , FL Wang , WD Fraser . Impact of preeclampsia and gestational hypertension on birth weight by gestational age. Am J Epidemiol 2002; 155: 203209.

30 RA Odegard , LJ Vatten , ST Nilsen , KA Salvesen , R Austgulen . Preeclampsia and fetal growth. Obstet Gynecol 2000; 96: 950–55.

31 R Xiao , TK Sorensen , MA Williams , DA Luthy . Influence of pre-eclampsia on fetal growth. J Matern Fetal Neonatal Med 2003; 13: 157–62.

32 CK Yu , O Khouri , N Onwudiwe , Y Spiliopoulos , KH Nicolaides . Prediction of pre-eclampsia by uterine artery doppler imaging: Relationship to gestational age at delivery and small-for-gestational age. Ultrasound Obstet Gynecol 2008; 31: 310–13.

33 E Groeneveld , KA Broeze , MJ Lambers , M Haapsamo , K Dirckx , BC Schoot et al.Is aspirin effective in women undergoing in vitro fertilization (IVF)? Results from an individual patient data meta-analysis (IPD MA). Hum Reprod Update 2011; 17: 501509.

34 MJ Lambers , E Groeneveld , DA Hoozemans , R Schats , R Homburg , CB Lambalk et al.Lower incidence of hypertensive complications during pregnancy in patients treated with low-dose aspirin during in vitro fertilization and early pregnancy. Hum Reprod 2009; 24: 2447–450.

35 M Haapsamo , H Martikainen , H Tinkanen , S Heinonen , S Nuojua-Huttunen , J Rasanen . Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: A randomized, placebo-controlled, double-blind study. Hum Reprod 2010; 25: 2972–977.

36 SP Kaandorp , M Goddijn , JA van der Post , BA Hutten , HR Verhoeve , K Hamulyak et al.Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010; 362: 1586–596.

37 CS Siristatidis , SR Dodd , AJ Drakeley . Aspirin is not recommended for women undergoing IVF. Hum Reprod Update 2012; 18: 233.

39 EA Steegers , P von Dadelszen , JJ Duvekot , R Pijnenborg . Pre-eclampsia. Lancet 2010; 376: 631–44.

41 R Pijnenborg , G Dixon , WB Robertson , I Brosens . Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980; 1: 319

42 M Haapsamo , H Martikainen , J Rasanen . Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: A randomized, placebo-controlled double-blind study. Ultrasound Obstet Gynecol 2008; 32: 687–93.

43 YM Kim , E Bujold , T Chaiworapongsa , R Gomez , BH Yoon , HT Thaler et al.Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003; 189: 10631069.

44 YM Kim , T Chaiworapongsa , R Gomez , E Bujold , BH Yoon , S Rotmensch et al.Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002; 187: 1137–142.

47 MM Werler , AA Mitchell , S Shapiro . The relation of aspirin use during the first trimester of pregnancy to congenital cardiac defects. N Engl J Med 1989; 321: 16391642.

48 B Norgard , E Puho , AE Czeizel , MV Skriver , HT Sorensen . Aspirin use during early pregnancy and the risk of congenital abnormalities: A population-based case-control study. Am J Obstet Gynecol 2005; 192: 922–23.

49 MA Klebanoff , HW Berendes . Aspirin exposure during the first 20 weeks of gestation and IQ at four years of age. Teratology 1988; 37: 249255.

50 SA Keim , MA Klebanoff . Aspirin use and miscarriage risk. Epidemiology 2006; 17: 435–39.

52 G Levy , JA Procknal , LK Garrettson . Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium. Clin Pharmacol Ther 1975; 18: 210–14.

55 B Schiessl , KT Schneider , A Zimmermann , F Kainer , K Friese , R Oberhoffer . Prenatal constriction of the fetal ductus arteriosus–related to maternal pain medication? Z Geburtshilfe Neonatol 2005; 209: 6568.

56 J Wyatt-Ashmead . Antenatal closure of the ductus arteriosus and hydrops fetalis. Pediatr Dev Pathol 2011; 14: 469–74.

57 TG Di Sessa , ML Moretti , A Khoury , DA Pulliam , KL Arheart , BM Sibai . Cardiac function in fetuses and newborns exposed to low-dose aspirin during pregnancy. Am J Obstet Gynecol 1994; 171: 892900.

58 A Leonhardt , S Bernert , B Watzer , G Schmitz-Ziegler , HW Seyberth . Low-dose aspirin in pregnancy: Maternal and neonatal aspirin concentrations and neonatal prostanoid formation. Pediatrics 2003; 111: e7781.

59 WA Bleyer , RT Breckenridge . Studies on the detection of adverse drug reactions in the newborn. II. The effects of prenatal aspirin on newborn hemostasis. JAMA. 1970; 213: 20492053.

60 DG Corby , I Schulman . The effects of antenatal drug administration on aggregation of platelets of newborn infants. J Pediatr 1971; 79: 307–13.

62 YE Rotchell , JK Cruickshank , MP Gay , J Griffiths , A Stewart , B Farrell et al.Barbados low dose aspirin study in pregnancy (blasp): A randomised trial for the prevention of pre-eclampsia and its complications. Br J Obstet Gynaecol 1998; 105: 286–92.

63 BM Sibai , SN Caritis , E Thom , M Klebanoff , D McNellis , L Rocco et al.Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The national institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1993; 329: 1213–218.

64 S Caritis , B Sibai , J Hauth , MD Lindheimer , M Klebanoff , E Thom et al.Low-dose aspirin to prevent preeclampsia in women at high risk. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med 1998; 338: 701705.

65 D Subtil , P Goeusse , F Puech , P Lequien , S Biausque , G Breart et al.Aspirin (100 mg) used for prevention of pre-eclampsia in nulliparous women: The essai regional aspirine mere-enfant study (part 1). BJOG 2003; 110: 475–84.

66 JC Hauth , RL Goldenberg , CR Parker Jr., GR Cutter , SP Cliver . Low-dose aspirin: Lack of association with an increase in abruptio placentae or perinatal mortality. Obstet Gynecol 1995; 85: 10551058

67 BM Sibai , SN Caritis , E Thom , K Shaw , D McNellis . Low-dose aspirin in nulliparous women: Safety of continuous epidural block and correlation between bleeding time and maternal-neonatal bleeding complications. National institute of child health and human developmental maternal-fetal medicine network. Am J Obstet Gynecol 1995; 172: 1553–557.

69 E Rey , GE Rivard . Is testing for aspirin response worthwhile in high-risk pregnancy? Eur J Obstet Gynecol Reprod Biol 2011; 157: 3842.

70 M Vainio , J Maenpaa , A Riutta , P Ylitalo , SL Ala-Fossi , R Tuimala . In the dose range of 0.5–2.0 mg/kg, acetylsalicylic acid does not affect prostacyclin production in hypertensive pregnancies. Acta Obstet Gynecol Scand 1999; 78: 8288

71 A Dumont , A Flahault , M Beaufils , E Verdy , S Uzan . Effect of aspirin in pregnant women is dependent on increase in bleeding time. Am J Obstet Gynecol 1999; 180: 135–40.

74 K Spencer , CK Yu , NJ Cowans , C Otigbah , KH Nicolaides . Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free BETA-HCG and with second-trimester uterine artery doppler. Prenat Diagn 2005; 25: 949–53.

75 LC Poon , NA Kametas , C Valencia , T Chelemen , KH Nicolaides . Hypertensive disorders in pregnancy: Screening by systolic diastolic and mean arterial` pressure at 11–13 weeks. Hypertens Pregnancy 2011; 30: 93107.

76 R Akolekar , A Etchegaray , Y Zhou , N Maiz , KH Nicolaides . Maternal serum activin a at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Fetal Diagn Ther 2009; 25: 320–27.

77 R Akolekar , R Minekawa , A Veduta , XC Romero , KH Nicolaides . Maternal plasma inhibin a at 11–13 weeks of gestation in hypertensive disorders of pregnancy. Prenat Diagn. 2009; 29: 753–60.

78 R Akolekar , A Syngelaki , J Beta , R Kocylowski , KH Nicolaides . Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn 2009; 29: 1103–108.

79 G Karagiannis , R Akolekar , R Sarquis , D Wright , KH Nicolaides . Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011; 29: 148–54.

80 LC Poon , NA Kametas , T Chelemen , A Leal , KH Nicolaides . Maternal risk factors for hypertensive disorders in pregnancy: A multivariate approach. J Hum Hypertens 2010; 24: 104–10.

81 LC Poon , NA Kametas , N Maiz , R Akolekar , KH Nicolaides . First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812–18.

82 LC Poon , NA Kametas , I Pandeva , C Valencia , KH Nicolaides . Mean arterial pressure at 11(+0) to 13(+6) weeks in the prediction of preeclampsia. Hypertension 2008; 51: 10271033

83 A Syngelaki , FE Bredaki , E Vaikousi , N Maiz , KH Nicolaides . Body mass index at 11–13 weeks’ gestation and pregnancy complications. Fetal Diagn Ther 2011; 30: 250–65.

84 GC Smith , CK Yu , AT Papageorghiou , AM Cacho , KH Nicolaides . Maternal uterine artery doppler flow velocimetry and the risk of stillbirth. Obstet Gynecol. 2007; 109: 144–51.

86 Y Giguere , M Charland , E Bujold , N Bernard , S Grenier , F Rousseau et al.Combining biochemical and ultrasonographic markers in predicting preeclampsia: A systematic review. Clin Chem 2010; 56: 361–75.

87 E Bujold , AM Morency , S Roberge , Y Lacasse , JC Forest , Y Giguere . Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery doppler: A systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818–26.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Fetal and Maternal Medicine Review
  • ISSN: 0965-5395
  • EISSN: 1469-5065
  • URL: /core/journals/fetal-and-maternal-medicine-review
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 4 *
Loading metrics...

Abstract views

Total abstract views: 71 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 29th May 2017. This data will be updated every 24 hours.